Joshua E. Ney, Ph.D.

With a Ph.D. in chemistry, Josh leverages his technical background to counsel clients on patent matters in a range of technology areas, including small molecule drugs, monoclonal antibodies, mRNA therapeutics, lipid nanoparticles, vaccines, CAR-T therapies, flow cytometry technology and polymer chemistry.

Josh’s patent procurement practice includes patent drafting, prosecution, and worldwide portfolio management in the life sciences industry, including for pharmaceutical products in ongoing Phase 3 clinical trials. He also provides freedom to operate analyses and opinions, due diligence and patent portfolio reviews.

Josh also represents pharmaceutical and biotechnology companies in patent litigation matters and pre-litigation due diligence. His litigation experience includes pharmaceutical litigation under the Hatch-Waxman Act on behalf of both innovator and generic pharmaceutical companies.